论文部分内容阅读
目的探讨瑞舒伐他汀联合脉血康胶囊在治疗高脂血症过程中的相关疗效。方法选取本院收治的86例高脂血症患者的临床资料,将所有的患者随机分为治疗组和对照组,每组患者均为43例。对照组患者采用瑞舒伐他汀治疗,治疗组是在对照组的基础上联合脉血康胶囊,两组患者在治疗相同时间之后,比较两组患者的TG、TC、HDL-C、LDL-C的变化情况。结果治疗组患者在治疗之后血脂改善情况明显优于对照组患者,两组患者之间的差异有统计学意义(P<0.05)。结论瑞舒伐他汀联合脉血康在治疗高脂血症的过程中,疗效显著、不良反应少,值得在临床中推广应用。
Objective To investigate the effect of rosuvastatin combined with pulse Xuekang capsule in the treatment of hyperlipidemia. Methods The clinical data of 86 patients with hyperlipemia admitted to our hospital were selected. All the patients were randomly divided into treatment group and control group, with 43 patients in each group. The patients in the control group were treated with rosuvastatin. The treatment group was on the basis of the control group with the combination of Maisuankang capsule. After treatment for the same time, TG, TC, HDL-C, LDL-C Changes in the situation. Results The improvement of blood lipids in the treatment group was significantly better than that in the control group after treatment. The difference between the two groups was statistically significant (P <0.05). Conclusion Rosuvastatin combined with pulse Xuekang in the treatment of hyperlipidemia in the process of significant effect, fewer adverse reactions, it is worth to promote the clinical application.